CliffBio
small molecule

DEXTROSE 5% AND SODIUM CHLORIDE 0.9%

DEXTROSE; SODIUM CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameDEXTROSE 5% AND SODIUM CHLORIDE 0.9%
Active ingredientDEXTROSE; SODIUM CHLORIDE
Strength5GM/100ML;900MG/100ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalSeptember 2020
Marketing statusRX

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.